Concizumab

A4DAB071 | Cardiovascular / hemostasis disorders | Approved
TFPI
G4 / IgG4
Novo Nordisk
Approved
Whole mAb
mAb-2021 mAb2021 NN-7415 NN7415
6
Avg A4D Score
-0.7296
Score Range
-0.73
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB071_4dtg_H_L 4dtg 100% -0.7296 6.5 4.0 -0.4318 -0.7704